Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice.

Source:http://linkedlifedata.com/resource/pubmed/id/16686956

Download in:

View as

General Info

PMID
16686956